Literature DB >> 21138653

The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549.

H Kolářová1, L Binó, K Pejchalová, L Kubala.   

Abstract

Controlled production of reactive oxygen species (ROS) by NADPH oxidases in non-phagocytic cells has recently been suggested to participate in the regulation of cellular functions. Due to the role of ROS in control of cellular functions, precise and accurate detection of ROS is of essential importance. However, various methodological approaches currently used for ROS determination vary in sensitivity, specificity, as well as in requirements for specialized equipment. In this study, human lung epithelial cell line A549 was screened for expression of NADPH oxidases NOX1, NOX2, NOX4, NOX5, DUOX1 and DUOX2 by quantitative RT-PCR. Fluorometric, colorimetric, and chemiluminometric methods were applied to determine ROS production. A549 cells were found to significantly express NOX1, NOX2, DUOX1 and DUOX2. ROS production by A549 cells was detected with fluorometric probes 2',7'-dichlorofluorescein- diacetate, dihydroethidium, and amplex red or colorimetric probe nitrobluetetrazolium. The production of ROS detected by these probes was partially reduced by NADPH oxidase inhibitor diphenyleneiodonium. The inhibitory effect of diphenyleneiodonium was the most significant regarding amplex red detection of phorbol myristate acetateactivated ROS production. In contrast to other probes, neither cytochrome c colorimetric determination nor luminol- and L-012-amplified chemiluminescence, regardless of the addition of horseradish peroxidase, exerted sufficient sensitivity to detect ROS production by A549. The results revealed differences among methods used for ROS formation measurement by human lung epithelial cell line A549 and highlighted the sensitivity of fluorometric determination for this purpose.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138653

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  6 in total

1.  Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3.

Authors:  Siying Ye; Sue Lowther; John Stambas
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  Endothelial NOX4 Oxidase Negatively Regulates Inflammation and Improves Morbidity During Influenza A Virus Lung Infection in Mice.

Authors:  Keshia S Hendricks; Eunice E To; Raymond Luong; Felicia Liong; Jonathan R Erlich; Ajay M Shah; Stella Liong; John J O'Leary; Doug A Brooks; Ross Vlahos; Stavros Selemidis
Journal:  Front Cell Infect Microbiol       Date:  2022-05-04       Impact factor: 6.073

3.  PAC1 regulates receptor tyrosine kinase transactivation in a reactive oxygen species-dependent manner.

Authors:  Terry W Moody; Lingaku Lee; Tatiana Iordanskaia; Irene Ramos-Alvarez; Paola Moreno; Howard E Boudreau; Thomas L Leto; Robert T Jensen
Journal:  Peptides       Date:  2018-09-28       Impact factor: 3.750

4.  Coinfection with Porcine Circovirus Type 2 (PCV2) and Streptococcus suis Serotype 2 (SS2) Enhances the Survival of SS2 in Swine Tracheal Epithelial Cells by Decreasing Reactive Oxygen Species Production.

Authors:  Qing Wang; Hong Zhou; Hongjie Fan; Xiaomin Wang
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

5.  A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.

Authors:  Ti-Wei Miao; De-Qing Yang; Fang-Ying Chen; Qi Zhu; Xin Chen
Journal:  Biosci Rep       Date:  2022-08-31       Impact factor: 3.976

6.  Opportunistic Pathogen Porphyromonas gingivalis Modulates Danger Signal ATP-Mediated Antibacterial NOX2 Pathways in Primary Epithelial Cells.

Authors:  JoAnn S Roberts; Kalina R Atanasova; Jungnam Lee; Gill Diamond; Jeff Deguzman; Chul Hee Choi; Özlem Yilmaz
Journal:  Front Cell Infect Microbiol       Date:  2017-07-04       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.